Source: Annual Congress 2005 - Interventions in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Bibi, D. Feigenbaum, M. Hessen, D. Shoseyov (Ashkelon, Jerusalem, Israel). Are current treatment protocols adequate for children with mild intermittent asthma?. Eur Respir J 2005; 26: Suppl. 49, 2540

Member's Comments

No comment yet.

Related content which might interest you: Is mild asthma outside the guidelines? Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 The management of mild asthma Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020 Year: 2021 From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 How much is too much? The treatment of mild asthma Source: Eur Respir J 2007; 30: 403-406 Year: 2007 The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003 Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Are current treatment recommendations suited to elderly patients with asthma or COPD? Source: Eur Respir Mon; 2009: 43: 267–285 Year: 2009 Control of persistent asthma patients on inhaled corticosteroids in a real-life setting Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010 A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Treatment of moderate persistent asthma: new options Source: Annual Congress 2007 - Pharmacological treatment of mild to moderate persistent asthma: new approaches Year: 2007 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 L-carnitine improves the asthma control in children with moderate persistent asthma Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005 Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 379s Year: 2004 Anti-IgE treatment in children with severe intrinsic asthma Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 A comparison of strategies to treat urban children with severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 315s Year: 2003